🇺🇸 FDA

Drug profile · INN

adapalene

EPIDUO

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

adapalene (EPIDUO) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN adapalene
Brand EPIDUO
Route TOPICAL
Formulation LOTION

Related patents

Search patents →

  1. US 11273132

    Topical dapsone and dapsone/adapalene compositions and methods for use thereof

    Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8871447

    Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is adapalene?

adapalene (EPIDUO) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for adapalene?

EPIDUO is a marketed brand name for adapalene. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of adapalene?

adapalene has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.